IQVIA Holdings | Les Charges D'Exploitation



Operating Expenses Changement Date
Accenture USD 14.41B 326.48M 2025-02
Adcock Ingram Holdings ZAR 4.23B 196.72M 2024-12
Agilent USD 1.31B 12M 2025-01
Bruker USD 915.5M 119.2M 2024-12
Cardinal Health USD 54.72B 3.01B 2024-12
Celltrion KRW 674.25B 128.01B 2024-09
Charles River Laboratories USD 1.17B 277.88M 2024-12
Cigna USD 63.35B 1.96B 2024-12
Cognizant Technology Solutions USD 4.26B 69M 2025-03
Cspc Pharmaceutical CNY 5.42B 102.74M 2024-09
CVS Health USD 94.85B 255M 2024-12
Danaher USD 4.46B 655M 2025-03
Dentsply International USD 1.41B 1000K 2024-12
Dianthus Therapeutics USD 33.24M 1.17M 2024-12
Elevance Health USD 46.09B 1.6B 2025-03
Hologic USD 792M 34M 2024-12
Humana USD 30.1B 342M 2025-03
IBM USD 13.38B 865M 2025-03
Illumina USD 929M 590M 2024-12
Infosys INR 323.5B 5.02B 2025-03
Kangmei Pharma CNY 1.46B 193.63M 2024-09
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 311.35M 170.35M 2024-12
Laboratory Of America USD 3.01B 100.2M 2025-03
Malin Corporation EUR 700K 1.6M 2024-06
McKesson USD 94.07B 997M 2024-12
Mettler Toledo International USD 730.58M 884.93M 2024-12
Organigram Holdings CAD 54.04M 9.62M 2024-12
Pharma Mar EUR 41.94M 1.53M 2025-03
Publicis EUR 7.17B 3.89B 2024-12
Qiagen NV USD 377.04M 4.6M 2024-12
Quest Diagnostics USD 2.31B 46M 2025-03
Revvity USD 592.53M 18.09M 2025-03
Sartorius EUR 745.6M 21.2M 2025-03
Sino Biopharmaceutical CNY 11.66B 5.46B 2024-12
Thermo Fisher Scientific USD 8.65B 731M 2025-03
Tilray USD 253.17M 16.55M 2024-11
UnitedHealth USD 100.47B 7.46B 2025-03
Veeva Systems USD 532.46M 14.61M 2025-01
Walgreens Boots Alliance USD 43.8B 4.12B 2025-02
Waters USD 580.45M 51.28M 2024-12
Zz Pientze Pharmaceu 1.96B 275.44K 2025-03



IQVIA Holdings Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.